STONY BROOK, N.Y. – July 2, 2019 – Applied DNA Sciences Inc. (NASDAQ: APDN) (“Applied DNA”, the “Company”), a leader in PCR-based DNA manufacturing for product authenticity and traceability solutions, announced today the signing of a five-year Agreement with Germany-based Montblanc-Simplo GMBH (“Montblanc”) for the provision of unique SigNature® DNA marks for [...]
Stony Brook, NY, May 15, 2019 – Applied DNA Sciences, Inc. (NASDAQ: APDN), announced today that partner TheraCann International Benchmark Corporation (“TheraCann”), a leading full service international cannabis consultancy and technology firm, in conjunction CannAcubed Pte Ltd (CannAcubed), a pioneer in the China cannabis space with a focus on building the world’s [...]
STONY BROOK N.Y., April 3, 2019 – Applied DNA Sciences Inc. (NASDAQ: APDN), a leader in PCR-based DNA manufacturing for product authenticity and traceability solutions, announced its recognition of and alignment with the Memorandum signed today by President Donald Trump to help protect American consumers, manufacturers, and factory workers from counterfeiting. Applied DNA is using its [...]
Brands and Manufacturers can be certain that their products are authentic STONY BROOK, N.Y., (February 27, 2018) – Applied DNA Sciences, Inc. (“Applied DNA,” “the Company,” NASDAQ: APDN), today announced that it is collaborating with American & Efird, (A&E), one of the world’s leading manufacturers and distributors of industrial and consumer sewing thread, embroidery thread, [...]
Collaboration to help thwart counterfeits with molecular tagging of capsules STONY BROOK, N.Y., (February 26, 2018) – Applied DNA Sciences, Inc. (“Applied DNA,” “the Company,” NASDAQ: APDN), and ACG have signed a memorandum of understanding (MoU) that will allow ACG to utilize Applied DNA’s proven SigNature® molecular tagging and authentication technologies to develop molecularly-tagged [...]
New Patent Strengthens the Company’s Robust Cotton Genotyping and Traceability Patent Portfolio STONY BROOK, N.Y., (February 22, 2018) – Applied DNA Sciences, Inc. (“Applied DNA,” “the Company,” NASDAQ: APDN), is pleased to announce the receipt of a Notice of Allowance for its U.S. Patent Application No. 14/191,947 (US 2014/0295423 A1) entitled Methods for Genetic [...]
STONY BROOK, N.Y. – February 8, 2018 - Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the "Company"), announced financial results for the fiscal 2018 first quarter ended December 31, 2017. “We made significant progress in the first quarter on the execution of our growth strategy to expand our base of business [...]
STONY BROOK, N.Y. July 5, 2017 – Applied DNA Sciences, Inc. (“Applied DNA,” “the Company,” NASDAQ: APDN), is pleased to announce the addition of two sponsors to the Company’s leather traceability project with BLC Leather Technology Centre (BLC). The Research Project, initiated following the signing of a Research Agreement between the two companies, seeks to [...]
STONY BROOK, N.Y. June 28, 2017 – Applied DNA Sciences, Inc. (“Applied DNA,” “the Company,” NASDAQ: APDN), announces today that it has entered into subscription agreements for a private placement of its Common Stock, par value $.001 per share, with a group of investors, including a key customer and all of the Company’s Executive Officers [...]